Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
10.69
+0.61 (6.05%)
Mar 31, 2026, 4:00 PM EDT - Market closed
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $196.65 million as of March 31, 2026. Its market cap has increased by 60.12% in one year.
Market Cap
196.65M
Enterprise Value
192.60M
1-Year Change
60.12%
Ranking
Category
Stock Price
$10.69
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $196.65M, a decrease of -37.01%. That is a compound annual growth rate of -15.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 185.43M | 33.31% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 219.43M |
| Keros Therapeutics | 217.48M |
| Fennec Pharmaceuticals | 212.02M |
| MediWound | 206.94M |
| Nuvectis Pharma | 204.78M |
| Compugen | 201.40M |
| Tonix Pharmaceuticals Holding | 195.32M |
| Adagene | 184.75M |